Knott David M Jr - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 100 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
Knott David M Jr ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,082,000
+19.5%
409,2920.0%1.30%
+19.8%
Q2 2022$2,579,000
-20.2%
409,292
+5.1%
1.08%
+5.2%
Q1 2022$3,231,000
+96.1%
389,292
+22.6%
1.03%
+84.1%
Q4 2021$1,648,000317,4920.56%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders